Ocular Inflammatory Disease

All recent advances in knowledge of inflammation and its management cannot be considered in a discussion of ocular inflammation. This review will deal only with selected topics of particular interest in relation to inflammation of the cornea and uveal tract.CorneaIn 1962, 5-iodo-2′-deoxyuridine (IDU) was shown to be the first agent therapeutically active against any true virus.1 , 2 This activity was initially demonstrated against corneal infection by the virus of herpes simplex. Although infection with herpes simplex in the skin may be trivial and short-lived, herpes-simplex keratitis is the most important specific keratitis in this country and is a prominent . . .